SHIMOHARA Koichi | Department of Applied Pharmacology, Kyoto Pharmaceutical University
スポンサーリンク
概要
- SHIMOHARA Koichiの詳細を見る
- 同名の論文著者
- Department of Applied Pharmacology, Kyoto Pharmaceutical Universityの論文著者
関連著者
-
SHIMOHARA Koichi
Department of Applied Pharmacology, Kyoto Pharmaceutical University
-
Morimoto Yasuo
Department Of Chemical Engineering Osaka Prefecture University
-
Sukamoto Takayuki
Department Of Pharmacology Jichi Medical School
-
Hara Hideaki
Department Of Biofunctional Evaluation Molecular Pharmacology Gifu Pharmaceutical University
-
Okabe Susumu
Department Of Applied Pharmacology Kyoto College Of Pharmacy
-
Tanaka Keiko
Department Of Anesthesiology Akashi Municipal Hospital
-
Oshima Shinya
Department of Pharmacology, New Drug Research Laboratories, Kanebo Ltd.
-
Niida Hiromichi
Department of Applied Pharmacology, Kyoto Pharmaceutical University
-
Shimohara Koichi
Department of Pharmacology, New Drug Research Laboratories, Kanebo Ltd.
-
Morimoto Yasuo
Department of Pharmacology, New Drug Research Laboratories, Kanebo, Ltd.
-
Sukamoto Takayuki
Department of Pharmacology, New Drug Research Laboratories, Kanebo, Ltd.
著作論文
- Effects of the New Anti-Ulcer Agent KB-5492 on Experimental Gastric Mucosal Lesions and Gastric Mucosal Defensive Factors, as Compared to Those of Teprenone and Cimetidine.
- Effects of KB-5492, 1-(3,4,5-trimethoxybenzyl)-4-((4-methoxyphenyl)oxycarbonylmethyl)piperazine monofumarate monohydrate, on gastric lesions and gastric secration in rats.
- 4-Methoxyphenyl 4-(3,4,5-Trimethoxybenzyl)-1-Piperazineacetate Monofumarate Monohydrate (KB-5492), a New Anti-Ulcer Agent with a Selective Affinity for the Sigma Receptor, Prevents Cysteamine-Induced Duodenal Ulcers in Rats by a Mechanism Different from T